https://orcid.org/0000-0001-9206-5837
Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anna Tichler, Dorijn FL Hertroijs, Dirk Ruwaard, Martijn CGJ Brouwers, Mickaël Hiligsmann, Judith D de Jong & Arianne MJ Elissen. (2023) Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes. Patient Preference and Adherence 17, pages 719-729.
Read now
Read now
Sagar Dholariya, Siddhartha Dutta, Ragini Singh, Deepak Parchwani, Amit Sonagra & Mehul Kaliya. (2023) Bexagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, for improvement of glycemia in type 2 diabetes mellitus: a systematic review and meta-analysis. Expert Opinion on Pharmacotherapy 0:0, pages 1-12.
Read now
Read now
Moritsugu Kimura, Masao Toyoda, Nobumichi Saito, Makiko Takahashi, Konomi Isozumi, Eri Kato, Daiji Kawanami & Masafumi Fukagawa. (2022) The Importance of Patient and Family Engagement, the Needs for Self-Monitoring of Blood Glucose (SMBG) – Our Perspectives Learned Through a Story of SMBG Assistive Devices Made by a Husband of the Patient with Diabetes. Diabetes, Metabolic Syndrome and Obesity 15, pages 1627-1638.
Read now
Read now
David M Williams & Jeffrey W Stephens. (2022) Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Response to Letter]. Diabetes, Metabolic Syndrome and Obesity 15, pages 741-742.
Read now
Read now
Ling-Ling Zhu & Quan Zhou. (2022) Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Letter]. Diabetes, Metabolic Syndrome and Obesity 15, pages 557-558.
Read now
Read now
Dilixia Simayi & Yaqun Guan. (2022) HTR1A Gene Polymorphism in Type 2 Diabetes Mellitus Comorbid with Major Depressive Disorder in a Chinese Population. Diabetes, Metabolic Syndrome and Obesity 15, pages 1597-1604.
Read now
Read now
Articles from other publishers (8)
Padmapritha Thamotharan, Seshadhri Srinivasan, Jothydev Kesavadev, Gopika Krishnan, Viswanathan Mohan, Subathra Seshadhri, Korkut Bekiroglu & Chiara Toffanin. (2023) Human Digital Twin for Personalized Elderly Type 2 Diabetes Management. Journal of Clinical Medicine 12:6, pages 2094.
Crossref
Crossref
Eugenia Piragine, Davide Petri, Alma Martelli, Vincenzo Calderone & Ersilia Lucenteforte. (2023) Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis. Journal of Clinical Medicine 12:5, pages 1981.
Crossref
Crossref
Robert M. Califf. (2023) Our National Approach to Diabetes. Diabetes Care 46:2, pages 252-254.
Crossref
Crossref
Andrew J. Krentz. 2023. Cardiovascular Endocrinology and Metabolism. Cardiovascular Endocrinology and Metabolism
39
81
.
Markku Laakso & Lilian Fernandes Silva. (2022) Genetics of Type 2 Diabetes: Past, Present, and Future. Nutrients 14:15, pages 3201.
Crossref
Crossref
Christodoula Kourtidou, Vasileios Rafailidis, Garyfallia Varouktsi, Efthimios Kanakis, Vassilios Liakopoulos, Timoleon-Achilleas Vyzantiadis, Maria Stangou, Smaragdi Marinaki & Konstantinos Tziomalos. (2022) Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population. Journal of Personalized Medicine 12:7, pages 1139.
Crossref
Crossref
Irina Claudia Anton, Liliana Mititelu-Tartau, Eliza Gratiela Popa, Mihaela Poroch, Vladimir Poroch, Delia Reurean Pintilei & Gina Eosefina Botnariu. (2022) Clinical Parameters Affecting the Therapeutic Efficacy of SGLT-2—Comparative Effectiveness and Safety of Dapagliflozin and Empagliflozin in Patients with Type 2 Diabetes. Healthcare 10:7, pages 1153.
Crossref
Crossref
Soroush Mohammadi Jouabadi, Tarunveer Singh Ahluwalia, Taulant Muka & Fariba Ahmadizar. (2022) Editorial: Pharmacoepidemiology in Diabetes Mellitus and its Complications: Focus on Response to Medications. Frontiers in Pharmacology 13.
Crossref
Crossref